CFLT vs COLL · rev $963.6M vs P/E 17, rev $181.9M
Confluent Inc (CFLT) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CFLT currently screens at market cap $11.13B. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CFLT and COLL stock pages for the full models.
Not investment advice.